{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:06:10Z","timestamp":1775012770249,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>In this article, we describe the role of radiology for diagnosis and follow-up of progressive fibrosing interstitial lung disease (PF-ILD). Patients with PF-ILD are at increased risk for early death without treatment. Clinical diagnosis of PF-ILD has been described in the literature. This manuscript reviews the radiographic diagnosis of PF-ILD and the unique CT characteristics associated with specific types of fibrosis. Ultimately, we believe that radiology has the potential to recognize progression early and thus make an important contribution to the multidisciplinary discussion for this important diagnosis.<\/jats:p>","DOI":"10.3389\/fmed.2021.679051","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:35:04Z","timestamp":1642048504000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Ahmad","family":"Abu Qubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Capaccione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elana J.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12931-019-1022-1","article-title":"The natural history of progressive fibrosing interstitial lung diseases","volume":"20","author":"Kolb","year":"2019","journal-title":"Respir Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMc1917224","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"382","author":"Raghu","year":"2020","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/jcm9061722","article-title":"Towards the essence of progressiveness: bringing progressive fibrosing interstitial lung disease (PF-ILD) to the next stage","volume":"9","author":"De Sadeleer","year":"2020","journal-title":"J Clin Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"190109","DOI":"10.1183\/16000617.0109-2019","article-title":"Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12325-020-01578-6","article-title":"Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician survey","volume":"38","author":"Olson","year":"2021","journal-title":"Adv Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"190022","DOI":"10.1183\/16000617.0022-2019","article-title":"Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis","volume":"28","author":"Collins","year":"2019","journal-title":"Eur Respir Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2100221","DOI":"10.1183\/13993003.00221-2021","article-title":"The burden of progressive fibrotic interstitial lung disease across the UK","volume":"58","author":"Simpson","year":"2021","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e25322","DOI":"10.1097\/MD.0000000000025322","article-title":"Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study","volume":"100","author":"Komatsu","year":"2021"},{"key":"B11","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","article-title":"Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0226084","DOI":"10.1371\/journal.pone.0226084","article-title":"Meta-analysis of the radiological and clinical features of usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)","volume":"15","author":"Ebner","year":"2020","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-020-1296-3","article-title":"Progression of fibrosing interstitial lung disease","volume":"21","author":"Wong","year":"2020","journal-title":"Respir Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"180071","DOI":"10.1183\/16000617.0071-2018","article-title":"Acute exacerbations of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Kolb","year":"2018","journal-title":"Eur Respir Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1183\/09059180.00004914","article-title":"Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?","volume":"23","author":"Wuyts","year":"2014","journal-title":"Eur Respir Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/medsci6030073","article-title":"Diagnosis of idiopathic pulmonary fibrosis: differential diagnosis","volume":"6","author":"Aburto","year":"2018","journal-title":"Med Sci (Basel)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.rmed.2017.03.020","article-title":"Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns","volume":"126","author":"Bennett","year":"2017","journal-title":"Respir Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ro.2018.12.006","article-title":"Probable UIP: What is the evidence that compels this classification and how is it different from the indeterminate category?","volume":"54","author":"Chung","year":"2019","journal-title":"Semin Roentgenol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2214\/AJR.15.15537","article-title":"JOURNAL CLUB: Evidence of interstitial lung disease on low-dose chest ct images: prevalence, patterns, and progression","volume":"206","author":"Salvatore","year":"2016","journal-title":"AJR Am J Roentgenol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.clinimag.2019.07.003","article-title":"Progression of probable UIP and UIP on HRCT","volume":"58","author":"Salvatore","year":"2019","journal-title":"Clin Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"180073","DOI":"10.1183\/16000617.0073-2018","article-title":"Role of imaging in progressive-fibrosing interstitial lung diseases","volume":"27","author":"Walsh","year":"2018","journal-title":"Eur Respir Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2214\/AJR.17.18384","article-title":"CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis","volume":"210","author":"Chung","year":"2018","journal-title":"AJR Am J Roentgenol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clinimag.2018.06.013","article-title":"Cross sectional imaging of pulmonary fibrosis translating pathology into radiology","volume":"51","author":"Salvatore","year":"2018","journal-title":"Clin Imaging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"555621","DOI":"10.19080\/CTCMI.2019.03.555621","article-title":"Connective tissue disease and its evolution on chest CT","volume":"3","author":"Salvatore","year":"2019","journal-title":"Curr Trends Clin Med Imaging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr Opin HIV AIDS."},{"key":"B28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2214\/AJR.18.20884","article-title":"Visual and automated CT measurements of lung volume loss in idiopathic pulmonary fibrosis","volume":"213","author":"Robbie","year":"2019","journal-title":"AJR Am J Roentgenol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.rcl.2016.05.013","article-title":"Imaging of hypersensitivity pneumonitis","volume":"54","author":"Magee","year":"2016","journal-title":"Radiol Clin North Am."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chest.2018.08.1076","article-title":"Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory","volume":"155","author":"Salisbury","year":"2019","journal-title":"Chest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.36141\/svdld.v37i2.8965","article-title":"The right upper lobe bronchus angle: A tool for differentiating fibrotic and non-fibrotic sarcoidosis","volume":"37","author":"Salvatore","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.679051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:35:07Z","timestamp":1642048507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.679051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":32,"alternative-id":["10.3389\/fmed.2021.679051"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.679051","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"679051"}}